Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.


Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Antiviral Therapy

These sections summarize the data on ritonavir-boosted nirmatrelvir, remdesivir, and other antiviral medications.

Antiviral Therapy Summary Recommendations

Review the Panel’s recommendations on the use of antiviral therapies in patients with COVID-19.


Remdesivir is a nucleotide analogue prodrug that is approved to treat COVID-19 in certain patients.

Ritonavir-Boosted Nirmatrelvir (Paxlovid)

Read about using ritonavir-boosted nirmatrelvir in patients with COVID-19.


Read about using molnupiravir in patients with COVID-19.


Interferons are a group of antiviral cytokines that are being evaluated to treat COVID-19.


Ivermectin is an antiparasitic drug that is being evaluated to treat COVID-19.

Table: Characteristics of Antiviral Agents

This table summarizes key characteristics of antiviral agents that have been evaluated for COVID-19.